home»çÀÌÆ®¸Êcontact us°ü¸®ÀÚÀü¿ë
°øÁö»çÇ×
´ëÇÑÀÇÇÐȸȸº¸
e - NEWSLETTER
ȸ¿øÇÐȸÇмú´ëȸ
ȸ¿øÇÐȸ »õ¼Ò½Ä
°ü·Ã´Üü »õ¼Ò½Ä
Á¦  ¸ñ [´ëÇѾϿ¬±¸Àç´Ü]Á¦19Â÷ ¼­¿ï±¹Á¦¾Ï½ÉÆ÷Áö¿ò °³ÃÖ
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀϽà 2011-11-10 10:03
÷ºÎÆÄÀÏ Ã·ºÎÆÄÀÏ1 - 1320887016_19th SICS Âü°¡½Åû¼­ ¹× program.doc19th SICS Âü°¡½Åû¼­ ¹× program.doc( size : 97 KBytes)
÷ºÎÆÄÀÏ2 - 1320887016_19Â÷ KFCR welcome message.docx19Â÷ KFCR welcome message.docx( size : 45 KBytes)
ÂüÁ¶ URL

Àç´Ü¹ýÀÎ ´ëÇѾϿ¬±¸Àç´Ü¿¡¼­´Â 11¿ù 29ÀÏ(È­) ¡®Á¦19Â÷ ¼­¿ï±¹Á¦¾Ï½ÉÆ÷Áö¿ò¡¯À» ¼­¿ïÀÇ´ë ¾Ï¿¬±¸¼Ò 2Ãþ ¡®À̰ÇÈñ Ȧ¡¯¿¡¼­ °³ÃÖÇÕ´Ï´Ù.

 

¢Â ÀϽÃ: 2011³â 11¿ù 29ÀÏ(È­) ¿ÀÈÄ 1:30 – 6:00

¢Â Àå¼Ò: ¼­¿ïÀÇ´ë ¾Ï¿¬±¸¼Ò 2F À̰ÇÈñȦ

¢Â µî·Ïºñ: ¾øÀ½

¢Â ¿¬¶ôó: ¼­¿ï´ëÇб³º´¿ø ¿Ü°ú ³» ´ëÇѾϿ¬±¸Àç´Ü »ç¹«½Ç

             ÀüÈ­) 02-747-0224   FAX) 02-3672-0047    E-MAIL) KFCR@paran.com

             ȨÆäÀÌÁö) http://koreanfcr.or.kr/

¢Â ÁÖÂ÷: ¾Ï¿¬±¸¼Ò Çà»çÀå ³» ÁÖÂ÷·á ¹«·á.

          ¼­¿ï´ëÇб³º´¿ø ¿ø³» ÁÖÂ÷ ½Ã ÁÖÂ÷ºñ º°µµÀ̹ǷΠ´ëÁß±³Åë ÀÌ¿ëÀ» ±ÇÀåÇÕ´Ï´Ù.

 

 - Âü°¡¸¦ Èñ¸ÁÇϽô ºÐÀº 2011³â 11¿ù 22(È­)±îÁö Âü°¡½Åû¼­¸¦ ÀÛ¼ºÇϼż­

À̸ÞÀÏ (KFCR@paran.com)·Î º¸³»Áֽñ⠹ٶø´Ï´Ù.

 

 

The 19th Seoul International Cancer Symposium

- Cancer Burden in Korea -

 

- Date : 2011. 11. 29 (Tue)

- Venue: Lee Kun Hee Auditorium, Cancer Research Institute, Seoul National University, Seoul, Korea
- Official language: Korean

- Host : Korean Foundation for Cancer Research

                                                                    

 

1:30-1:50 PM       Registration

1:50-2:00       Opening remarks: Cancer burden in Korea

¾ÈÀ±¿Á (´ëÇѾϿ¬±¸Àç´Ü ÀÌ»çÀå, ¼­¿ïÀÇ´ë)

Session I : Effectiveness of early detection programs in Korea

Chair: À¯¼¼È­(°í·ÁÀÇ´ë), ¹Úº´ÁÖ(¼­¿ïÀÇ´ë)

 

2:00-2:15  ¿ì¸®³ª¶ó ¾Ï ºÎ´ã ºÐ¼® ¹× °¨Ãà¹æ¾È °³¹ß                            ¹ÚÀºÃ¶ (¿¬¼¼ÀÇ´ë)

2:15-2:30  Æó¾Ï Á¶±âÁø´Ü°ú ¼ö¼ú ÈÄ ¿¹ÈÄ ¿¹Ãø                                 Àü»óÈÆ (¼­¿ïÀÇ´ë)

2:30-2:45  Prognostic Implication of New Pathologic Classsification of Solitary Pulmonary Nodular Lung

Adenocarcinoma: Correlation with Multimodality Imaging Biomarker Studies

À̰æ¼ö (»ï¼º¼­¿ïº´¿ø)

2:45-3:00  Discussion

 

Special Session : Invited lecture                     Chair: ¾ÈÀ±¿Á (´ëÇѾϿ¬±¸Àç´Ü ÀÌ»çÀå, ¼­¿ïÀÇ´ë)

3:00-3:30  Cancer burden in Japan                           Nobuo Koinuma (Tohoku University, Japan)

3:30-3:40  Discussion

 

3:40-4:00  coffee break

 

Session II :  Award Session

 

4:00-4:05 ¾Ï¿¬±¸¹Ú»çÇÐÀ§³í¹® Àú¼ú Áö¿ø »ç¾÷ °æ°ú ¹× °á°ú º¸°í        ±è´ë¿ë (¼­¿ï´ë ¼öÀÇÇаú)

4:05-4:10 Á¦6ȸ ±èÁøº¹¾Ï¿¬±¸»ó °æ°ú ¹× °á°ú º¸°í                           ¾çÇѱ¤ (¼­¿ïÀÇ´ë)

4:10-4:20 Á¦6ȸ ±èÁøº¹¾Ï¿¬±¸»ó ¼ö»óÀÚ ¹ßÇ¥

4:20-4:30 ½Ã»ó½Ä 

 

Session III : Control strategy for recent emerging cancer; thyroid and prostate cancers

Chair: Á¶º¸¿¬(Áß¾ÓÀÇ´ë), À强±¸(°æÈñÀÇ´ë)

 

4:30-4:45    °©»ó¼±¾Ï ¹ßº´¿äÀÎ ±Ô¸í°ú °á°ú¿¬±¸¸¦ ÅëÇÑ Á¶±â¹ß°ß ¹× Ä¡·áÀÇ À¯È¿¼º Æò°¡ ¿¬±¸ ÁøÇà

»óȲº¸°í                                                         À±¿©±Ô (¼­¿ïÀÇ´ë)

4:45-5:00   Çѱ¹ÀÎ °©»ó¼±¾ÏÀÇ Æ¯Â¡                                         Á¤ÀçÈÆ (¼º±Õ°üÀÇ´ë)

5:00-5:10  Discussion

 

5:10-5:25     Development of new tumor markers for prostate cancer                  ÀÌÇö¹« (¼º±Õ°üÀÇ´ë)
5:25-5:40     Àü¸³¼±¾Ï Á¶±âÁø´Ü°ú Àû±ØÀû Ä¡·á°¡ ÇÊ¿äÇÑ Àü¸³¼±¾ÏÀÇ ¼±º°À» À§ÇÑ ¿¹Ãø Ç¥ÁöÀÚ ¹×

¸ðµ¨ °³¹ß                                                        ÃÖ¿µµæ (¿¬¼¼ÀÇ´ë)

5:40-5:50  Discussion

 

5:50      Closing remarks

 

 

 


Àüü °Ô½Ã¹°À» º¾´Ï´Ù.
¼Ò°³ ¼Ò½Ä/Çà»ç ÀÇÇÐȸȸ¿ø ÀÚ·á½Ç °Ç°­±³À° °ü·Ã»çÀÌÆ®